Lupus erythematosus tumidus: clinical perspectives
Nikolaos Patsinakidis,1,2 Ocko Kautz,1 Bernhard F Gibbs,2 Ulrike Raap1,2 1University Clinic of Dermatology and Allergology, University of Oldenburg, Klinikum Oldenburg Aör, Oldenburg, Germany; 2Division of Experimental Allergy and Immunodermatology,
Patsinakidis N +3 more
doaj
Abstract A 5‐year‐old, spayed, female Shiba Inu was presented with a 6‐week history of reduced appetite, lethargy and generalised stiffness, which showed only limited improvement despite anti‐inflammatory treatment. The most significant clinical abnormalities were pyrexia, stiffness, pain on joint manipulation and cutaneous lesions. Laboratory findings
Jeanne Bergeat +6 more
wiley +1 more source
Discoid Lupus Erythematosus in Genital Skin: A Case Report and Review of the Literature
ABSTRACT Background Discoid lupus erythematosus (DLE) represents the most common variant of chronic cutaneous lupus erythematosus, a skin‐specific autoimmune disorder within the broader lupus erythematosus spectrum Clinically, DLE is characterized by erythematous, scaly plaques with areas of hyperpigmentation.
Ala' Abu‐Dayeh +2 more
wiley +1 more source
Bilateral Earlobe Purpura as an Unusual Initial Manifestation of Systemic Lupus Erythematosus: A Case Report. [PDF]
Atherton L.
europepmc +1 more source
Persistent Annular Eruptions in a 2‐Year‐Old Girl
Pediatric Dermatology, EarlyView.
Harisankeerth Mummareddy +3 more
wiley +1 more source
Subcutaneous panniculitis‐like T‐cell lymphoma. Survival outcomes according to the presence of hemophagocytic lymphohistiocytosis (HLH) and T category. Relapse‐free survival was inferior in patients presenting with generalized (T3) skin lesions. Overall survival was poor in patients with HLH. Relapse‐free survival was also reduced in patients with HLH.
Myoung Eun Choi +6 more
wiley +1 more source
Anifrolumab, a monoclonal antibody targeting the interferon-1 receptor, is currently approved for the treatment of moderate- to-severe systemic lupus erythematosus, but emerging evidence highlights its potential efficacy in cases with predominant ...
Gilberto P. da Rosa +6 more
doaj
Osimertinib, a Trigger of Subacute Cutaneous Lupus Erythematosus: Three-Patient Case Series and Literature Review. [PDF]
Nowiszewska J +6 more
europepmc +1 more source
Higher postoperative complication rates in patients with systemic lupus erythematosus undergoing surgical and obstetric procedures: a nationwide retrospective matched cohort study. [PDF]
Silva FE, de Abreu MM.
europepmc +1 more source
Case Report: Anifrolumab for Refractory Cutaneous Lupus Erythematosus: Relapse After Treatment Interruption and Response to Rechallenge. [PDF]
Peng Y, Stidham S, Tariq F, Zaheer M.
europepmc +1 more source

